Clinical Trials List
Protocol NumberFB704ACLIS-05
Completed
2023-02-01 - 2024-12-30
Phase II
Terminated2
-
Trial Applicant
ONENESS BIOTECH CO., LTD.
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
0 participants
